Last updated on November 2016

A Phase 3 Clinical Trial for Patients with Nonalcoholic Steatohepatitis (NASH)


Brief description of study

A Phase 3 Clinical Trial for Patients with Nonalcoholic Steatohepatitis (NASH)

Detailed Study Description

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Study Evaluating the Safety and Efficacy of Obeticholic Acid (study medication) in Subjects with Nonalcoholic Steatohepatitis (NASH).

Clinical Study Identifier: TX146343

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )